Trump slams reports about Russia trying to influence US election through Facebook adsWorld September 22, 14:57
Stalin, Lenin busts unveiled at Walk of Rulers in MoscowSociety & Culture September 22, 14:49
Russia’s Sberbank to leave some European countries due to sanctionsBusiness & Economy September 22, 14:19
Kremlin spokesman declines to comment on Tillerson’s criticism of RussiaRussian Politics & Diplomacy September 22, 14:01
First serial-produced nuclear-powered icebreaker Sibir floated out in St. PetersburgMilitary & Defense September 22, 13:51
Russian submarine hits terrorist targets in SyriaMilitary & Defense September 22, 13:41
Russia never placed political ads on Facebook — KremlinRussian Politics & Diplomacy September 22, 13:24
China calls on all parties to abandon provocations and pass on to talks on Korea problemWorld September 22, 13:14
Russia expects South Korea to ensure security at Winter Olympics — KremlinSport September 22, 13:13
MOSCOW, October 11. /TASS/. Russian tennis star Maria Sharapova can participate in exhibition matches as it does not violate the terms of her current suspension, the International Tennis Federation (ITF) told TASS.
Sharapova, who is currently under suspension over anti-doping rules violations, participated recently in the exhibition matches at the tennis tournament in Las Vegas.
"Exhibition events are not covered events under the Tennis Anti-Doping Program so Sharapova is able to participate," the ITF said in its statement addressed to TASS.
Sharapova has been serving a two-year suspension for the violation of anti-doping regulations since January 26. However, the Swiss-based Court of Arbitration for Sport (CAS) ruled October 4 to reduce her suspension term from 24 to 15 months.
The Russian player is now eligible to officially return back to tennis courts starting April 26 next year.
In early March, Sharapova was first to announce that her doping tests revealed the presence of performance enhancing drug meldonium in the body system. Following the announcement, former World’s No. 1 was provisionally suspended from all tennis-related activities.
On June 9, Sharapova filed an appeal with the CAS in Switzerland’s Lausanne against her two-year suspension, which was officially announced on June 8 by the International Tennis Federation (ITF) Tribunal over anti-doping violations.
Due to the imposed ban Sharapova, the silver Olympic medalist of the 2012 Games in London, had to miss the 2016 Summer Olympic Games, held in August in Brazil’s Rio de Janeiro.
Mildronate is a cardiovascular preparation freely available for purchase at pharmacies across Russia without a doctor’s prescription.